| Title |
Available evidence and outcome of off-label use of rituximab in clinical practice
|
|---|---|
| Published in |
European Journal of Clinical Pharmacology, May 2013
|
| DOI | 10.1007/s00228-013-1518-4 |
| Pubmed ID | |
| Authors |
I. Danés, A. Agustí, A. Vallano, J. Martínez, C. Alerany, A. Ferrer, A. López, J. Cortés-Hernández, J. A. Bosch |
| Abstract |
To analyze the therapeutic indications for off-label use of rituximab, the available evidence for its use, the outcomes, and the cost. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 70 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 11 | 16% |
| Student > Master | 11 | 16% |
| Other | 7 | 10% |
| Student > Postgraduate | 7 | 10% |
| Student > Bachelor | 5 | 7% |
| Other | 18 | 26% |
| Unknown | 11 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 25 | 36% |
| Agricultural and Biological Sciences | 5 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
| Immunology and Microbiology | 3 | 4% |
| Psychology | 3 | 4% |
| Other | 13 | 19% |
| Unknown | 16 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 May 2013.
All research outputs
#20,194,150
of 22,711,242 outputs
Outputs from European Journal of Clinical Pharmacology
#2,381
of 2,552 outputs
Outputs of similar age
#170,502
of 195,532 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#24
of 25 outputs
Altmetric has tracked 22,711,242 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,552 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 195,532 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.